Zikang Bio

智康弘义

Zikang Bio

Biotech/Healthcare

Wuxi Zhikang Hongyi Biotechnology aims to become a pharmaceutical technology and product company with sustained leadership in innovation. Guided by clinical value and urgent unmet needs, it focuses on challenging and high-priority clinical areas.

Latest round: Series A Extension (2024)

Source: ChinaBulls — chinabulls.com

Last updated 2024-08-01